-
Start Preamble
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, “Non-Human Primate Immune Tolerance Cooperative Study Group”.
Date: October 29-30, 2001.
Time: October 29, 2001, 8:30 am to adjournment.
Agenda: To review and evaluate grant applications.
Place: Embassy Square, 2000 N Street, NW., Washington, DC 20036.
Contact Person: Priti Mehrotra, PhD, Scientific Review Administrator, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, 301-496-2550, pm158b@nih.gov
Start Signature(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)
Dated: August 30, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-22464 Filed 9-6-01; 8:45 am]
BILLING CODE 4140-01-M
Document Information
- Effective Date:
- 10/29/2001
- Published:
- 09/07/2001
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 01-22464
- Dates:
- October 29-30, 2001.
- Pages:
- 46806-46806 (1 pages)
- PDF File:
- 01-22464.pdf